Literature DB >> 29897100

Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm.

Daniel H Moreno1, Daniel G Cacione, Jose Cc Baptista-Silva.   

Abstract

BACKGROUND: An abdominal aortic aneurysm (AAA) is the pathological enlargement of the aorta and can develop in both men and women. Progressive aneurysm enlargement can lead to rupture. The rupture of an AAA is frequently fatal and accounts for the death from haemorrhagic shock of at least 45 people per 100,000 population. The outcome of people with ruptured AAA varies among countries and healthcare systems, with mortality ranging from 53% to 90%. Definitive treatment for ruptured AAA includes open surgery or endovascular repair. The management of haemorrhagic shock is crucial for the person's outcome and aims to restore organ perfusion and systolic blood pressure above 100 mmHg through immediate and aggressive fluid replacement. This rapid fluid replacement is known as the normotensive resuscitation strategy. However, evidence suggests that infusing large volumes of cold fluid causes dilutional and hypothermic coagulopathy. The association of these factors may exacerbate bleeding, resulting in a 'lethal triad' of hypothermia, acidaemia, and coagulopathy. An alternative to the normotensive resuscitation strategy is the controlled (permissive) hypotension resuscitation strategy, with a target systolic blood pressure of 50 mmHg to 100 mmHg. The principle of controlled or hypotensive resuscitation has been used in some management protocols for endovascular repair of ruptured AAA. It may be beneficial in preventing blood loss by avoiding the clot disruption caused by the rapid increase in systolic blood pressure; avoiding dilution of clotting factors, platelets and fibrinogen; and by avoiding the temperature decrease that inhibits enzyme activity involved in platelet and clotting factor function. This is an update of a review first published in 2016.
OBJECTIVES: To compare the effects of controlled (permissive) hypotension resuscitation and normotensive resuscitation strategies for people with ruptured AAA. SEARCH
METHODS: The Cochrane Vascular Information Specialist searched the Specialised Register (August 2017), the Cochrane Register of Studies (CENTRAL (2017, Issue 7)) and EMBASE (August 2017). The Cochrane Vascular Information Specialist also searched clinical trials databases (August 2017) for details of ongoing or unpublished studies. SELECTION CRITERIA: We sought all published and unpublished randomised controlled trial (RCTs) that compared controlled hypotension and normotensive resuscitation strategies for the management of shock in patients with ruptured abdominal aortic aneurysms. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed identified studies for potential inclusion in the review. We used standard methodological procedures in accordance with the Cochrane Handbook for Systematic Review of Interventions. MAIN
RESULTS: We identified no RCTs that met the inclusion criteria. AUTHORS'
CONCLUSIONS: We found no RCTs that compared controlled hypotension and normotensive resuscitation strategies in the management of haemorrhagic shock in patients with ruptured abdominal aortic aneurysm that assessed mortality, presence of coagulopathy, intensive care unit length of stay, and the presence of myocardial infarct and renal failure. High quality studies that evaluate the best strategy for managing haemorrhagic shock in ruptured abdominal aortic aneurysms are required.

Entities:  

Mesh:

Year:  2018        PMID: 29897100      PMCID: PMC6513606          DOI: 10.1002/14651858.CD011664.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  20 in total

1.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

Review 2.  Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery.

Authors:  F L Moll; J T Powell; G Fraedrich; F Verzini; S Haulon; M Waltham; J A van Herwaarden; P J E Holt; J W van Keulen; B Rantner; F J V Schlösser; F Setacci; J-B Ricco
Journal:  Eur J Vasc Endovasc Surg       Date:  2011-01       Impact factor: 7.069

3.  Ruptured abdominal aortic aneurysm.

Authors:  E S Crawford
Journal:  J Vasc Surg       Date:  1991-02       Impact factor: 4.268

4.  Risk factors for rupture of abdominal aortic aneurysm based on three-dimensional study.

Authors:  T Hatakeyama; H Shigematsu; T Muto
Journal:  J Vasc Surg       Date:  2001-03       Impact factor: 4.268

5.  Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants.

Authors:  L C Brown; J T Powell
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

6.  The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm.

Authors:  Elliot L Chaikof; Ronald L Dalman; Mark K Eskandari; Benjamin M Jackson; W Anthony Lee; M Ashraf Mansour; Tara M Mastracci; Matthew Mell; M Hassan Murad; Louis L Nguyen; Gustavo S Oderich; Madhukar S Patel; Marc L Schermerhorn; Benjamin W Starnes
Journal:  J Vasc Surg       Date:  2018-01       Impact factor: 4.268

Review 7.  Endovascular treatment for ruptured abdominal aortic aneurysm.

Authors:  Stephen Badger; Rachel Forster; Paul H Blair; Peter Ellis; Frank Kee; Denis W Harkin
Journal:  Cochrane Database Syst Rev       Date:  2017-05-26

Review 8.  Hypotensive resuscitation in patients with ruptured abdominal aortic aneurysm.

Authors:  K Roberts; M Revell; H Youssef; A W Bradbury; D J Adam
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-01-04       Impact factor: 7.069

Review 9.  Controlled hypotension versus normotensive resuscitation strategy for people with ruptured abdominal aortic aneurysm.

Authors:  Daniel H Moreno; Daniel G Cacione; Jose C C Baptista-Silva
Journal:  Cochrane Database Syst Rev       Date:  2016-05-13

10.  Mortality from ruptured abdominal aortic aneurysms: clinical lessons from a comparison of outcomes in England and the USA.

Authors:  Alan Karthikesalingam; Peter J Holt; Alberto Vidal-Diez; Baris A Ozdemir; Jan D Poloniecki; Robert J Hinchliffe; Matthew M Thompson
Journal:  Lancet       Date:  2014-03-15       Impact factor: 79.321

View more
  4 in total

1.  Recovery of organ-specific tissue oxygen delivery at restrictive transfusion thresholds after fluid treatment in ovine haemorrhagic shock.

Authors:  Wayne B Dyer; Gabriela Simonova; Sara Chiaretti; Mahe Bouquet; Rebecca Wellburn; Silver Heinsar; Carmen Ainola; Karin Wildi; Kei Sato; Samantha Livingstone; Jacky Y Suen; David O Irving; John-Paul Tung; Gianluigi Li Bassi; John F Fraser
Journal:  Intensive Care Med Exp       Date:  2022-04-04

2.  Finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy.

Authors:  Hao-Yang Wang; Ming-Cheng Yuan; Fu-Xing Pei; Zong-Ke Zhou; Ren Liao
Journal:  J Orthop Surg Res       Date:  2020-08-25       Impact factor: 2.359

3.  Profiling of the full-length transcriptome in abdominal aortic aneurysm using nanopore-based direct RNA sequencing.

Authors:  Hai Xin; Xingqiang He; Jun Li; Xiaomei Guan; Xukui Liu; Yuewei Wang; Liyuan Niu; Deqiang Qiu; Xuejun Wu; Haofu Wang
Journal:  Open Biol       Date:  2022-02-02       Impact factor: 6.411

4.  The efficacy of esmolol, remifentanil and nitroglycerin in controlled hypotension for functional endoscopic sinus surgery.

Authors:  Aslı Alkan; Mehtap Honca; Ali Alkan; Handan Güleç; Eyüp Horasanlı
Journal:  Braz J Otorhinolaryngol       Date:  2019-10-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.